Below 4 hrly Chart, not really strong in either direction and...

Below 4 hrly Chart, not really strong in either direction and watching the book today is evident that bots have taken hold of this stock.
Expecting the Quarterly tomorrow to have no real surprises but just reaffirm what we know - as someone mentioned today.
- FDA approval of a safe product with demand
- Sitting on a castle of cash
- Prepping for sales in the short term to start turning revenue

Its hard to say that a 4C that contains everything we already know will cause the stock to break to the upside of this pennant but this will be our strongest report ever. If any fund is interested and sitting on the sideline, the quarterly will give the black and white of where this company sits, and it sits well.
Volume signature indicates a move is coming, both buyers and sellers have stopped (but we are still holding near highs which always tips the scales to the bulls)

$XBI biotech ETF is not giving away any hints either, chart is choppy. With August approaching I believe people will look for a safe bet, and maybe $BOT fits that category. Talks of takeovers also too soon imo, the wait for sales and figures continues..

JD